Prediction: Eli Lilly Stock Could Be a Long-Term Winner for Investors

Eli Lilly just crushed earnings again and sits within striking distance of its all-time high, but a looming price war with Novo Nordisk and a dangerously concentrated revenue base raise real questions about how long the momentum holds.